Ospedale Giovanni Paolo II
- Address
- Via Vittorio Tiralongo, 97100 Ragusa, Italy
Ospedale Giovanni Paolo II - Cardiovascular Research Center
Ospedale Giovanni Paolo II is a specialized cardiovascular research center focused on advancing treatments for acute cardiac conditions and cardiac arrhythmias. The facility demonstrates expertise in interventional cardiology and anticoagulation therapy, conducting pivotal trials that address critical gaps in cardiovascular care for high-risk patient populations.
- Acute myocardial infarction management with novel drug-eluting stent technologies and modified antiplatelet regimens
- Stroke prevention strategies in atrial fibrillation patients unsuitable for conventional oral anticoagulation
- Complete revascularization approaches in complex acute coronary syndrome cases
The center's research portfolio emphasizes personalized therapeutic strategies for patients with acute myocardial infarction and atrial fibrillation, particularly those requiring alternative treatment options due to complexity or contraindications to standard therapies. Their investigations into modified antiplatelet therapy combined with advanced coronary stent systems, alongside novel anticoagulation agents for stroke prevention, position the hospital at the forefront of cardiovascular innovation aimed at improving outcomes in challenging clinical scenarios.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ospedale Giovanni Paolo II
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Modified Antiplatelet Therapy with Prasugrel, Ticagrelor, and Acetylsalicylic Acid in Acute Myocardial Infarction Patients Post-Revascularization | SORIN CRM SAS (Microport CRM) | Phase III | Not Recruiting | Jun 2021 | Mar 2025 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2021-06-29 | 2021-06-29 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.